Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826026) titled 'Rectal Indomethacin With or Without Papillary Ice Water Irrigation to Prevent Post-ERCP Pancreatitis' on Sept. 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Unity Health Toronto

Condition: Pancreatitis

Intervention: Drug: Rectal Indomethacin

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 120

To know more, visit https://clinicaltrials.gov/study/NCT07826026

Disclaimer: Curated by HT Sy...